News

According to terms of the agreement, Lorus will provide Sumitomo proprietary antisense oligonucleotides complementary to Thioredoxin mRNA, specifically the lead drug candidate, GTI-2601. The collaboration agreement provides for

These findings have been highlighted in a report carried out by the House of Commons Health Committee. In the report, the committee stated that UK regulatory authority the

JA-001 (sorivudine, also known as ARYS-01 cream) has previously demonstrated activity against the varicella zoster virus in both preclinical and clinical studies. Janus plans to conduct clinical studies

A licensing agreement was signed between the two companies in March this year, granting Gilead the exclusive rights to Japan Tobacco’s novel HIV integrase inhibitor, JTK-303, in all

In the studies, mice treated with second-generation investigational immune regulating hormone (IRH) compounds showed increased survival and dramatically reduced inflammation compared to placebo treated animals. Benefit was achieved

The investigational new drug (IND) filing seeks to evaluate LGD2941 as a potential new therapy for the treatment of osteoporosis and frailty. LGD2941 is a selective androgen receptor

Under the terms of the new agreement, Genentech has committed to pay Curis an up-front license fee of $3 million and up to an additional $6 million over

The complaints, launched in 2001 and 2003, alleged that Biovail’s listing with the FDA of a patent for Tiazac (diltiazem) improperly delayed the entry of a competing generic

Virus types to be screened as part of the collaboration potentially include herpes viruses, respiratory viruses, pox viruses, hepatitis B and C, papillomavirus and viruses of biodefense concern